盖茨基金会与 Flagship Pioneering 合作：五年最高2500万美元找全球健康新解法
总部位于华盛顿州 Seattle 的盖茨基金会与位于马萨诸塞州 Cambridge 的科学创新机构 Flagship Pioneering 11月12日宣布启动合作，共同出资寻找能惠及中低收入国家弱势人群的健康与农业突破方案。
这项合作将依托 Flagship 旗下的创新工场 Flagship Labs 及其生态中 40 多家突破性平台公司（业务横跨人类健康与地球健康），结合盖茨基金会在全球健康、女性健康与农业方面的深厚经验，寻找与这些优先领域契合的新型健康与农业解法，缩短科学发现走向实际产品的路径。
合作的核心是在 Flagship 内部设立一项新倡议 Pioneering Global Health & Development（PGH&D），由高级合伙人 Dr. Raj Panjabi 领衔。Panjabi 是医生与创业者，曾领导 Flagship 的预防健康与医学倡议，此前担任白宫全球卫生安全与生物防御高级主任，并曾领导美国总统疟疾倡议。
两家机构已共同承诺在五年内出资最高2500万美元，用于设立与运行 PGH&D 团队。团队将围绕全球健康、女性健康与农业组建一批项目，每个项目后续可再获双方追加资金支持推进开发。
Flagship Labs 执行合伙人、首席企业发展官兼首席运营官 Justine Levin-Allerhand 表示，衡量创新不只看它在科学上能做到什么，也看它的好处能惠及多广的人群；把盖茨基金会对相关需求的理解与 Flagship 孵化突破平台与产品的能力结合起来，可以从一开始就把可及性与影响力建进创新里，为把雄心勃勃的科学变成惠及常被落在后面的人群的解法，开出一条新路。
此次合作建立在盖茨基金会此前对三家 Flagship 旗下公司最高9200万美元投入的基础上：ProFound Therapeutics、Tessera Therapeutics 与 Sail Biomedicines，分别面向子痫与子痫前期、镰状细胞病与艾滋病、疟疾等方向，为中低收入国家的弱势人群推进可负担的进展。双方表示，PGH&D 将把这种合作做成更系统的模式，从 Flagship 的整个生态中筛选机会，把概念一路推进到项目与现实影响。
Flagship Pioneering 成立于2000年，已创立与培育 100 多家科学企业，当前生态包含 40 多家公司，其在2024年7月最新一轮募资后管理的资产为 140 亿美元。盖茨基金会总部位于 Seattle，由首席执行官 Mark Suzman 领导，在 Bill Gates 与理事会指导下运作。
（来源：盖茨基金会）
Gates Foundation and Flagship Pioneering Launch Collaboration With Up to $25 Million Over Five Years
The Gates Foundation, based in Seattle, Washington, and Flagship Pioneering, a scientific innovation engine based in Cambridge, Massachusetts, announced on Nov. 12 a collaboration to fund the discovery of potential breakthrough health and agricultural solutions to benefit underserved populations in low- and middle-income countries.
The collaboration will leverage Flagship Labs, the company's innovation foundry, along with Flagship's ecosystem of more than 40 breakthrough platform companies spanning human and planetary health, together with the Gates Foundation's deep expertise in global health, women's health, and agriculture. The two organizations aim to identify novel health and agricultural solutions aligned with these priorities and to shorten the path from scientific discovery to products capable of improving lives across low- and middle-income countries.
At the center of the work will be a new initiative operated within Flagship, Pioneering Global Health & Development (PGH&D), led by Dr. Raj Panjabi, Senior Partner. A physician and entrepreneur, Dr. Panjabi has helped lead Flagship's Preemptive Health and Medicine Initiative, is a former White House Senior Director for Global Health Security and Biodefense, and previously led the U.S. President's Malaria Initiative.
The Gates Foundation and Flagship have jointly committed up to $25 million over a five-year period to establish and operate the PGH&D group. Through this work, the organizations aim to identify and initiate a portfolio of programs across global health, women's health, and agriculture, with each program considered for additional funding from both entities for further development.
"The true measure of innovation is not only what it makes scientifically possible, but also how broadly its benefits can reach," said Justine Levin-Allerhand, Executive Partner, Chief Corporate Development Officer and Chief Operating Officer of Flagship Labs. She said that by combining the Gates Foundation's deep understanding of global health, women's health and agricultural innovation needs with Flagship's capacity to originate and develop breakthrough platforms and products, the partners can build access and impact into innovation from the very beginning.
The collaboration builds on Gates Foundation investments of up to $92 million in three Flagship companies: ProFound Therapeutics, Tessera Therapeutics, and Sail Biomedicines, supporting accessible advancements in eclampsia and pre-eclampsia, sickle cell disease and HIV, and malaria, respectively, in service of underserved populations in low- and middle-income countries.
Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, operating with $14 billion of assets under its direction as of its latest capital raise, announced in July 2024. The Gates Foundation is based in Seattle, Washington, and is led by CEO Mark Suzman, under the direction of Bill Gates and its governing board.
(Source: Gates Foundation)
来源：盖茨基金会
发布：GSM·美国（发布链接）
图片来源：盖茨基金会西雅图园区航拍，Sea Cow 摄，CC BY-SA 4.0，经 Wikimedia Commons / Gates Foundation campus in Seattle, aerial view, by Sea Cow, CC BY-SA 4.0, via Wikimedia Commons
GSM Global · 本篇英文版 English edition of this story
